S. Pelton

发表

Characterization of antigens from nontypable Haemophilus influenzae recognized by human bactericidal antibodies. Role of Haemophilus outer membrane proteins.

S. Gulati, P. Rice, H. Gnehm, 1985, The Journal of clinical investigation.

Nontypeable Haemophilus influenzae as a Pathogen in Children

J. Campos, A. Forsgren, L. Bakaletz, 2009, The Pediatric infectious disease journal.

Emergence of 19A as Virulent and Multidrug Resistant Pneumococcus in Massachusetts Following Universal Immunization of Infants With Pneumococcal Conjugate Vaccine

Susan S. Huang, W. Hanage, J. Kellenberg, 2007, The Pediatric infectious disease journal.

Emergence of 19 A as Virulent and Multidrug Resistant Pneumococcus in Massachusetts Following Universal Immunization of Infants With Pneumococcal Conjugate Vaccine

Susan S. Huang, W. Hanage, J. Kellenberg, 2007 .

Population genomics of post-vaccine changes in pneumococcal epidemiology

M. Lipsitch, W. Hanage, J. Parkhill, 2013, Nature Genetics.

Otitis media and its consequences: beyond the earache.

E. Sanders, E. Simões, A. Hoberman, 2010, The Lancet. Infectious diseases.

Constancy of distribution of serogroups of invasive pneumococcal isolates among children: experience during 4 decades.

F. Babl, J. Klein, S. Pelton, 2001, Clinical infectious diseases : an official publication of the Infectious Diseases Society of America.

Direct and Indirect Effects of PCV13 on Nasopharyngeal Carriage of PCV13 Unique Pneumococcal Serotypes in Massachusetts’ Children

S. Pelton, K. Hsu, C. Marchant, 2014, The Pediatric infectious disease journal.

Formulations for trans-tympanic antibiotic delivery.

R. Langer, J. Rosowski, D. Kohane, 2013, Biomaterials.

Carried Pneumococci in Massachusetts Children: The Contribution of Clonal Expansion and Serotype Switching

Susan S. Huang, M. Lipsitch, W. Hanage, 2011, The Pediatric infectious disease journal.

Clonal replacement among 19A Streptococcus pneumoniae in Massachusetts, prior to 13 valent conjugate vaccination.

M. Lipsitch, W. Hanage, S. Rifas-Shiman, 2011, Vaccine.

New concepts in otitis media: results of investigations of the Greater Boston Otitis Media Study Group.

D. Teele, J. Klein, S. Pelton, 1992, Advances in pediatrics.

Epidemiology of invasive pneumococcal disease in the Arabian Peninsula and Egypt.

Z. Memish, S. Pelton, A. Shibl, 2009, International journal of antimicrobial agents.

Differential occurrence of Streptococcus pneumoniae serotype 11E between asymptomatic carriage and invasive pneumococcal disease isolates reflects a unique model of pathogen microevolution.

M. Nahm, S. Pelton, R. Dagan, 2012, Clinical infectious diseases : an official publication of the Infectious Diseases Society of America.

Antibody response to measles and rubella vaccine by children with HIV infection.

S. Pelton, E. Cooper, A. Brena, 1993, Journal of acquired immune deficiency syndromes.

CME Overview The Global Burden of Acute Otitis Media in Children: Outcomes, Management and Prospects for Prevention

S. Pelton, -. Editor, .. Editor, 2007 .

Early neurodevelopmental growth in children with vertically transmitted human immunodeficiency virus infection.

S. Pelton, C. Chase, M. Vibbert, 1995, Archives of pediatrics & adolescent medicine.

Radiographic resolution of lymphocytic interstitial pneumonitis (LIP) in children with human immunodeficiency virus (HIV): not a sign of clinical deterioration

F. Babl, S. Pelton, J. Blickman, 2001, Pediatric Radiology.

Cost of routine immunization of young children against rotavirus infection with Rotarix versus RotaTeq.

G. Oster, S. Pelton, D. Weycker, 2009, Vaccine.

Effect of Maternal Vaccination on the Immunogenicity of PCV-10 in HIV-exposed Uninfected Infants: A Randomized Study of PCV-10, PPV-23 or Placebo Administered during Pregnancy.

F. Bone, D. Goldblatt, S. Pelton, 2021 .

UNDERLYING CONDITIONS IN CHILDREN WITH INVASIVE PNEUMOCOCCAL DISEASE IN THE CONJUGATE VACCINE ERA

S. Pelton, K. Hsu, A. Arguedas, 2011 .

Impact of the 13-Valent Pneumococcal Conjugate Vaccine on Invasive Pneumococcal Disease After Introduction Into Routine Pediatric Use

W. Gruber, S. Pelton, R. Baxter, 2020, Journal of the Pediatric Infectious Diseases Society.

Effectiveness of Centers for Disease Control and Prevention Recommendations for Outcomes of Acute Otitis Media

H. Bauchner, T. Heeren, S. Pelton, 2006, Pediatrics.

Pneumococcal Disease in the Era of Pneumococcal Conjugate Vaccine.

S. Pelton, K. Shea, I. Yildirim, 2015, Infectious disease clinics of North America.

Antibody to a conserved antigenic target is protective against diverse prokaryotic and eukaryotic pathogens

W. Garrett, D. Golenbock, G. Pier, 2013, Proceedings of the National Academy of Sciences.

Tympanometry in the diagnosis of middle-ear effusion.

S. Pelton, P. Shurin, J. Finkelstein, 1977, The New England journal of medicine.

User-friendly smartphone detection of middle ear fluid.

S. Pelton, Vishakha Sabharwal, 2020, Jornal de Pediatria.

Prospects for Prevention of Otitis Media

S. Pelton, 2007, The Pediatric infectious disease journal.

Recent Advances in Otitis Media

S. Pelton, E. Leibovitz, 2009, The Pediatric infectious disease journal.

Persistence of middle-ear effusion after acute otitis media in children.

J. Klein, S. Pelton, P. Shurin, 1979, The New England journal of medicine.

Bacteriology of acute otitis media unresponsive to initial antimicrobial therapy.

D. Teele, J. Klein, S. Pelton, 1981, The Journal of pediatrics.

Pandemic Response Requires Research Samples: A U.S. Safety-Net Hospital's Experience and Call for National Action

Grace Q. Zhao, C. Andry, E. Burks, 2021, Annals of Internal Medicine.

Who is at risk of 13-valent conjugated pneumococcal vaccine failure?

P. Keskinocak, S. Pelton, L. Pickering, 2020, Vaccine.

Brief Client-Centered Motivational and Behavioral Intervention to Promote HPV Vaccination in a Hard-to-Reach Population

K. Freund, S. Pelton, J. Bernstein, 2016, Clinical pediatrics.

Switch from ritonavir to indinavir in combination therapy for HIV-1-infected children.

C. Fletcher, S. Pelton, R. Yogev, 2005, Clinical infectious diseases : an official publication of the Infectious Diseases Society of America.

Response to Toumi et al

G. Oster, S. Pelton, D. Weycker, 2010 .

Invasive Pneumococcal Disease After Implementation of 13-Valent Conjugate Vaccine

L. Madoff, S. Pelton, P. I. Tam, 2014, Pediatrics.

Bacteremia in febrile children under 2 years of age: results of cultures of blood of 600 consecutive febrile children seen in a "walk-in" clinic.

J. Herskowitz, D. Teele, J. Klein, 1975, The Journal of pediatrics.

Immunologic response to combination nucleoside analogue plus protease inhibitor therapy in stable antiretroviral therapy-experienced human immunodeficiency virus-infected children.

S. Lee, W. Borkowsky, S. Douglas, 2000, The Journal of infectious diseases.

Rethinking Risk for Pneumococcal Disease in Adults: The Role of Risk Stacking

S. Pelton, D. Weycker, J. Edelsberg, 2015, Open forum infectious diseases.

Impact of 13-Valent Pneumococcal Conjugate Vaccination on Streptococcus pneumoniae Carriage in Young Children in Massachusetts.

W. Hanage, K. Kleinman, N. Croucher, 2014, Journal of the Pediatric Infectious Diseases Society.

Panel 6: Vaccines

A. Hakansson, K. Mason, L. Bakaletz, 2013, Otolaryngology--head and neck surgery : official journal of American Academy of Otolaryngology-Head and Neck Surgery.

The Global Evolution of Meningococcal Epidemiology Following the Introduction of Meningococcal Vaccines.

S. Pelton, 2016, The Journal of adolescent health : official publication of the Society for Adolescent Medicine.

Acute otitis media in the era of effective pneumococcal conjugate vaccine: will new pathogens emerge?

S. Pelton, 2000, Vaccine.

Panel 6

A. Leach, L. Bakaletz, S. Pelton, 2013, Otolaryngology--head and neck surgery : official journal of American Academy of Otolaryngology-Head and Neck Surgery.

Strain characteristics of Streptococcus pneumoniae carriage and invasive disease isolates during a cluster-randomized clinical trial of the 7-valent pneumococcal conjugate vaccine.

K. O'Brien, M. Lipsitch, C. Thompson, 2007, Journal of Infectious Diseases.

Variation of Pneumococcal Pilus-1 Expression Results in Vaccine Escape during Experimental Otitis Media [EOM]

V. Masignani, S. Pelton, M. Moschioni, 2014, PloS one.

Prevention of invasive meningococcal disease in the United States.

S. Pelton, 2009, The Pediatric infectious disease journal.

The challenge of preventing invasive pneumococcal disease in children with comorbid illnesses.

S. Pelton, 2013, Clinical infectious diseases : an official publication of the Infectious Diseases Society of America.

Evolving Picture of Invasive Pneumococcal Disease in Massachusetts Children: A Comparison of Disease in 2007–2009 With Earlier Periods

S. Pelton, K. Hsu, I. Yildirim, 2012, The Pediatric infectious disease journal.

Changing Serotypes Causing Childhood Invasive Pneumococcal Disease: Massachusetts, 2001–2007

S. Pelton, K. Hsu, K. Shea, 2009, The Pediatric infectious disease journal.

Capsular switching as a strategy to increase pneumococcal virulence in experimental otitis media model.

S. Pelton, K. Trzciński, A. Stevenson, 2014, Microbes and infection.

Bactericidal antibody and susceptibility to otitis media caused by nontypable strains of Haemophilus influenzae.

D. Kasper, I. Tager, S. Pelton, 1980, The Journal of pediatrics.

Characteristics of Serotype 3 Invasive Pneumococcal Disease before and after Universal Childhood Immunization with PCV13 in Massachusetts

H. Cabral, S. Pelton, K. Shea, 2020, Pathogens.

Infants at Risk for Invasive Pneumococcal Disease in the 13-Valent Pneumococcal Conjugate Vaccine Era.

S. Pelton, I. Yildirim, 2018, Clinical infectious diseases : an official publication of the Infectious Diseases Society of America.

Vaccination, Underlying Comorbidities, and Risk of Invasive Pneumococcal Disease

S. Pelton, K. Shea, I. Yildirim, 2015, Pediatrics.

Risk of pneumococcal disease in children with chronic medical conditions in the era of pneumococcal conjugate vaccine.

S. Pelton, D. Weycker, J. Edelsberg, 2014, Clinical infectious diseases : an official publication of the Infectious Diseases Society of America.

Population-Based Surveillance for Childhood Invasive Pneumococcal Disease in the Era of Conjugate Vaccine

J. Klein, S. Pelton, D. Heisey-Grove, 2005, The Pediatric infectious disease journal.

Individual Benefit vs Societal Effect of Antibiotic Prescribing for Preschool Children With Recurrent Wheeze.

S. Pelton, R. Cohen, 2015, JAMA.

Panel 8: Vaccines and immunology.

L. Hammitt, A. Kurabi, Jian-Dong Li, 2019, International journal of pediatric otorhinolaryngology.

Differential effects of pneumococcal vaccines against serotypes 6A and 6C.

J. Treanor, B. Mahon, M. Nahm, 2008, The Journal of infectious diseases.

Immunization, Antibiotic Use, and Pneumococcal Colonization Over a 15-Year Period

M. Lipsitch, W. Hanage, K. Kleinman, 2017, Pediatrics.

Pneumococcal Carriage and Antibiotic Resistance in Young Children Before 13-valent Conjugate Vaccine

M. Lipsitch, W. Hanage, K. Kleinman, 2012, The Pediatric infectious disease journal.

Increase in the prevalence of the newly discovered pneumococcal serotype 6C in the nasopharynx after introduction of pneumococcal conjugate vaccine.

M. Nahm, J. Finkelstein, S. Pelton, 2009, The Journal of infectious diseases.

Capacity of Pneumococci to Activate Macrophage Nuclear Factor &kgr;B: Influence on Necroptosis and Pneumonia Severity

Matthew R. Jones, D. Kotton, S. Pelton, 2017, The Journal of infectious diseases.

Public health and economic impact of the 13-valent pneumococcal conjugate vaccine (PCV13) in the United States.

M. Weinstein, S. Pelton, K. Klugman, 2010, Vaccine.

Nontypeable Streptococcus pneumoniae as an otopathogen.

M. Pichichero, S. Pelton, R. Kaur, 2011, Diagnostic microbiology and infectious disease.

Title Emergence of 19 A as Virulent and Multidrug Resistant Pneumococcus in Massachusetts Following Universal Immunization of Infants With Pneumococcal Conjugate Vaccine

W. Hanage, J. Kellenberg, J. Finkelstein, 2007 .

1105Chronic Kidney Disease and Invasive Pneumococcal Disease in Adults

S. Pelton, B. Fireman, V. Snow, 2014, Open Forum Infectious Diseases.

Meningococcal Disease Awareness: Clinical and Epidemiological Factors Affecting Prevention and Management in Adolescents

S. Pelton, 2010 .

Modification of otitis media in chinchillas rechallenged with nontypable Haemophilus influenzae and serological response to outer membrane antigens.

P. Rice, H. Gnehm, S. Pelton, 1985, The Journal of infectious diseases.

Residency training in general pediatrics. Career direction of primary care graduates.

S. Pelton, J. Alpert, O. Mathieu, 1989, American journal of diseases of children.

Immune response to pneumococcal conjugate and polysaccharide vaccines in otitis-prone and otitis-free children.

R. Eavey, J. Klein, S. Pelton, 1999, Clinical infectious diseases : an official publication of the Infectious Diseases Society of America.

Overcoming Current Obstacles in the Management of Bacterial Community-Acquired Pneumonia in Ambulatory Children

S. Pelton, M. Hammerschlag, 2005, Clinical pediatrics.

Diseases in Infants and Children The Future of Pneumococcal Conjugate Vaccines for Prevention of Pneumococcal

J. Klein, S. Pelton, 2011 .

Cost-effectiveness of pneumococcal conjugate vaccine: an update after 7 years of use in the United States.

S. Pelton, K. Klugman, G. Ray, 2009, Vaccine.

Effectiveness of abbreviated and delayed 7-valent pneumococcal conjugate vaccine dosing regimens.

B. Mahon, S. Pelton, S. Kaplan, 2006, Vaccine.

Heptavalent pneumococcal conjugate vaccine: current and future impact

S. Pelton, K. Hsu, 2003, Expert Review of Vaccines.

The future of pneumococcal conjugate vaccines for prevention of pneumococcal diseases in infants and children.

J. Klein, S. Pelton, 2002, Pediatrics.

Disproportionate Exposure to Antibiotics in Children at Risk for Invasive Pneumococcal Disease: Potential for Emerging Resistance and Opportunity for Antibiotic Stewardship

S. Pelton, W. Kaplan, K. Outterson, 2019, Journal of the Pediatric Infectious Diseases Society.

Rates of pneumonia among children and adults with chronic medical conditions in Germany

S. Pelton, D. Weycker, D. Strutton, 2015, BMC Infectious Diseases.

Pneumococcal conjugate vaccines: proceedings from an interactive symposium at the 41st Interscience Conference on Antimicrobial Agents and Chemotherapy.

K. O'Brien, S. Pelton, R. Dagan, 2003, Vaccine.

Efficacy of Linezolid in Experimental Otitis Media

S. Pelton, D. Stalker, M. Figueira, 2000, Antimicrobial Agents and Chemotherapy.

Immunogenicity in high-risk and immunocompromised children and adults.

N. French, S. Pelton, S. Nachman, 2008 .

Modeling the impact of the 13-valent pneumococcal conjugate vaccine serotype catch-up program using United States claims data

M. Weinstein, S. Pelton, K. Klugman, 2012, BMC Infectious Diseases.

Differential Effects of Pneumococcal Vaccines against Serotypes 6 A and 6 C In

J. Treanor, B. Mahon, M. Nahm, 2008 .

Seven Valent Pneumococcal Conjugate Vaccine Immunization in Two Boston Communities: Changes in Serotypes and Antimicrobial Susceptibility Among Streptococcus pneumoniae Isolates

S. Pelton, C. Marchant, A. Loughlin, 2004, The Pediatric infectious disease journal.

Multinational study of pneumococcal serotypes causing acute otitis media in children

G. Yothers, S. Pelton, S. Kaplan, 2002, The Pediatric infectious disease journal.

Upper respiratory tract infections: etiology, current treatment, and experience with fluoroquinolones.

S. Pelton, R. Dagan, J. Butzler, 1998, Clinical microbiology and infection : the official publication of the European Society of Clinical Microbiology and Infectious Diseases.

To Treat or Not to Treat Is the Nagging Question

S. Pelton, R. Yogev, 2010, Pediatrics.

Effectiveness and impact of the 10-valent pneumococcal conjugate vaccine, PHiD-CV: review of clinical trials and post-marketing experience

T. Mrkvan, S. Pelton, D. Borys, 2018, Expert review of vaccines.

Clinically based surveillance of invasive meningococcal disease in young children admitted to selected US hospitals between January 2000 and June 2009

G. Oster, J. Stoddard, J. Klein, 2012, Human vaccines & immunotherapeutics.

The promise of immunoprophylaxis for prevention of acute otitis media.

J. Klein, S. Pelton, Jerome O. Klein, 1999, The Pediatric infectious disease journal.

Regulation of bacterial trafficking in the nasopharynx.

S. Pelton, 2012, Paediatric respiratory reviews.

Mini-Symposium: Recurrent Lower Respiratory Tract Infections Regulation of bacterial trafficking in the nasopharynx

S. Pelton, 2012 .

6. Vaccine

T. Heikkinen, L. Bakaletz, S. Pelton, 2005 .

Otitis media: re-evaluation of diagnosis and treatment in the era of antimicrobial resistance, pneumococcal conjugate vaccine, and evolving morbidity.

S. Pelton, 2005, Pediatric clinics of North America.

Pertussis Booster Vaccination in HIV-Infected Children Receiving Highly Active Antiretroviral Therapy

W. Borkowsky, K. Edwards, M. Levin, 2007, Pediatrics.

Bacterial etiology of otitis media during the first six weeks of life.

J. Klein, S. Pelton, P. Shurin, 1978, The Journal of pediatrics.

4. Microbiology, Immunology, Biochemistry, and Vaccination

D. L. Klein, A. Ryan, S. Hellström, 1994 .

Adolescents at Risk: The Case for Meningococcal Vaccine

M. Mahoney, S. Pelton, 2010 .

Expanding prevention of invasive meningococcal disease

S. Pelton, G. Gilmet, 2009, Expert review of vaccines.

Immunogenicity and safety of MenACWY-TT, a quadrivalent meningococcal tetanus toxoid conjugate vaccine recently licensed in the United States for individuals ≥2 years of age

S. Pelton, C. Robertson, P. Oster, 2022, Human vaccines & immunotherapeutics.

Clinical aspects of meningococcal disease

M. Sadarangani, S. Pelton, M. Levin, 2016 .

Frequency of pertussis in children with prolongued cough

S. Pelton, M. Ceyhan, G. Seçmeer, 2008, Scandinavian journal of infectious diseases.

Detection of group B streptococcal bacteremia in simulated intrapartum antimicrobial prophylaxis.

S. Pelton, D. S. Shapiro, K. Hsu, 2003, Diagnostic microbiology and infectious disease.

Pneumonia in young adults with asthma: impact on subsequent asthma exacerbations

S. Pelton, R. Sato, D. Weycker, 2019, Journal of asthma and allergy.

Prevalence and Genetic Diversity of Nontypeable Haemophilus influenzae in the Respiratory Tract of Infants and Primary Caregivers

S. Pelton, C. Marchant, A. Loughlin, 2012, The Pediatric infectious disease journal.

The immunogenicity of Haemophilus influenzae type b conjugate vaccines in children born to human immunodeficiency virus-infected women. Women and Infants Transmission Study Group.

M. Fowler, J. Clemens, C. Frasch, 1998, The Pediatric infectious disease journal.

Do community-level predictors of pneumococcal carriage continue to play a role in the conjugate vaccine era?

K. Kleinman, S. Rifas-Shiman, J. Finkelstein, 2013, Epidemiology and Infection.

Modifying acute otitis media: implications of immunization with pneumococcal conjugate vaccine.

S. Pelton, 2004, The Pediatric infectious disease journal.

Risk factors for invasive pneumococcal disease in children: a population-based case-control study in North America.

S. Pelton, 2000, Pediatrics.

Otitis media caused by non-typable, ampicillin-resistant strains of Haemophilus influenzae.

J. Klein, S. Pelton, D. Scheifele, 1976, The Journal of pediatrics.

Safety, immunogenicity, and transplacental antibody transport of conjugated and polysaccharide pneumococcal vaccines administered to pregnant women with HIV: a multicentre randomised controlled trial.

D. Goldblatt, S. Pelton, J. Pinto, 2021, The lancet. HIV.

Preclinical in vitro and in vivo profile of a highly-attenuated, broadly efficacious pneumolysin genetic toxoid

K. Killeen, R. Tweten, S. Pelton, 2020, Vaccine.

Immunogenicity and immunologic memory after hepatitis B virus booster vaccination in HIV-infected children receiving highly active antiretroviral therapy.

W. Borkowsky, M. Levin, S. Pelton, 2009, The Journal of infectious diseases.

Deconstructing Pneumococcal Progression from Colonization to Disease

S. Pelton, 2018, Infection and Immunity.

Rates and costs of invasive pneumococcal disease and pneumonia in persons with underlying medical conditions

S. Pelton, D. Weycker, J. Edelsberg, 2016, BMC Health Services Research.

A one year experience: T cell responses and viral replication in children with advanced human immunodeficiency virus type 1 disease treated with combination therapy including ritonavir.

S. Pelton, R. Yogev, D. Johnson, 1999, The Pediatric infectious disease journal.

Clinical and Economic Outcomes Associated with Cell-Based Quadrivalent Influenza Vaccine vs. Standard-Dose Egg-Based Quadrivalent Influenza Vaccines during the 2018–19 Influenza Season in the United States

M. Postma, G. Krishnarajah, S. Pelton, 2021, Vaccines.

Replacement pneumococcal disease in perspective.

S. Pelton, 2008, Clinical infectious diseases : an official publication of the Infectious Diseases Society of America.

Abnormal body-fat distribution in HIV-1-infected children on antiretrovirals

F. Babl, S. Pelton, A. Regan, 1999, The Lancet.

Effect of monophosphoryl lipid A (MPL) on T-helper cells when administered as an adjuvant with pneumocococcal-CRM197 conjugate vaccine in healthy toddlers.

J. Eldridge, S. Pelton, H. Bernstein, 2002, Vaccine.

Conjugate meningococcal vaccines: lifesaving or inefficient use or both-no easy answer.

S. Pelton, 2010, Clinical infectious diseases : an official publication of the Infectious Diseases Society of America.

7-Valent pneumococcal conjugate vaccine and lower respiratory tract infections: effectiveness of a 2-dose versus 3-dose primary series.

G. Oster, J. Klein, S. Pelton, 2010, Vaccine.

Immunogenicity, Safety, and Predictors of Response After a Pneumococcal Conjugate and Pneumococcal Polysaccharide Vaccine Series in Human Immunodeficiency Virus-Infected Children Receiving Highly Active Antiretroviral Therapy

W. Borkowsky, M. Levin, S. Pelton, 2006, The Pediatric infectious disease journal.

Vaccination for the prevention of acute otitis media: proof of concept and current challenges.

S. Pelton, 2002, Pediatric annals.

Prevention of invasive pneumococcal disease in HIV-infected children: expanding the toolbox.

S. Pelton, M. Abzug, 2009, The Journal of infectious diseases.

Multisystem Inflammatory Syndrome in an Adult With COVID-19—A Trial of Anakinra

Julie M. Herlihy, E. Cohen, S. Pelton, 2021, Infectious diseases in clinical practice.

Diagnosis of human immunodeficiency virus type 1 infection in infants by immune complex dissociation p24 assay

S. Pelton, E. Abrams, S. Landesman, 1997, Clinical and diagnostic laboratory immunology.

Challenges in the Management of Otitis Media

S. Pelton, 1999 .

5. Animal Models of Otitis Media

W. Doyle, A. Ryan, S. Hellström, 1989 .

Treatment of Streptococcus pneumoniae otitis media in a chinchilla model by transtympanic delivery of antibiotics.

D. Kohane, S. Pelton, Vishakha Sabharwal, 2018, JCI insight.

Treatment of otitis media by transtympanic delivery of antibiotics

John J. Rosowski, Daniel S. Kohane, Shutao Guo, 2016, Science Translational Medicine.

Bullous Skin Disease: An Unusual Allergic Reaction to Vancomycin

S. Pelton, E. Beutner, R. Magnussen, 2002, The American journal of the medical sciences.

A nonfatal case and 2 fatal cases of paraneoplastic pemphigus: can a complement indirect immunofluorescent test help to identify fatal "group A" paraneoplastic pemphigus cases?

T. Hashimoto, S. Pelton, E. Beutner, 2002, Journal of the American Academy of Dermatology.

Severity of Invasive Pneumococcal Disease in Children Caused by Susceptible and Nonsusceptible Isolates

L. Madoff, S. Pelton, P. Iroh Tam, 2014, The Pediatric infectious disease journal.

Clinical and Genetic Perspectives in Primary Immunodeficiency Disorders

J. Milunsky, S. Pelton, 2004 .

PERSISTENCE OF MIDDLE EAR EFFUSION AFTER OTITIS MEDIA

J. Klein, S. Pelton, P. Shurin, 1977, Pediatric Research.

Rates of Pneumococcal Disease in Adults With Chronic Medical Conditions

Kimberly M. Shea, S. Pelton, John Edelsberg, 2014, Open forum infectious diseases.

Case records of the Massachusetts General Hospital. Case 27-2006. A 17-year-old boy with fever and lesions in the liver and spleen.

S. Pelton, R. Kradin, John Y. Kim, 2006, The New England journal of medicine.

Otoscopy for the diagnosis of otitis media.

S. Pelton, S I Pelton, 1998, The Pediatric infectious disease journal.

21 – Meningococcal vaccines

L. Harrison, D. Granoff, S. Pelton, 2013 .

A Behavioral and Cognitive Profile of Clinically Stable HIV-Infected Children

L. Mofenson, S. Pelton, R. Yogev, 2006, Pediatrics.

Phase I evaluation of zidovudine administered to infants exposed at birth to the human immunodeficiency virus.

S. Pelton, J. Modlin, S. Weller, 1993, The Journal of pediatrics.

Post-PCV7 Changes in Colonizing Pneumococcal Serotypes in 16 Massachusetts Communities, 2001 and 2004

Richard Platt, Susan S Huang, Sheryl L Rifas-Shiman, 2004, Pediatrics.

Forty-eight-week evaluation of lopinavir/ritonavir, a new protease inhibitor, in human immunodeficiency virus-infected children

O. Ramilo, A. Hsu, D. Kempf, 2003, The Pediatric infectious disease journal.

Nucleoside analogs plus ritonavir in stable antiretroviral therapy-experienced HIV-infected children: a randomized controlled trial. Pediatric AIDS Clinical Trials Group 338 Study Team.

S. Lee, W. Borkowsky, L. Mofenson, 2000, JAMA.

Growth in human immunodeficiency virus-infected children receiving ritonavir-containing antiretroviral therapy.

J. Lindsey, L. Mofenson, S. Pelton, 2002, Archives of pediatrics & adolescent medicine.

Reconstitution of Virus-Specific CD4 Proliferative Responses in Pediatric HIV-1 Infection 1

B. Walker, M. Feeney, P. Goulder, 2003, The Journal of Immunology.

Pharmacokinetics of High-Dose Lopinavir-Ritonavir with and without Saquinavir or Nonnucleoside Reverse Transcriptase Inhibitors in Human Immunodeficiency Virus-Infected Pediatric and Adolescent Patients Previously Treated with Protease Inhibitors

W. Borkowsky, G. Aldrovandi, S. Pelton, 2008, Antimicrobial Agents and Chemotherapy.

Pharmacokinetic Characteristics of Ritonavir, Zidovudine, Lamivudine, and Stavudine in Children with Human Immunodeficiency Virus Infection

C. Fletcher, S. Pelton, R. Yogev, 2004, Pharmacotherapy.

HIV-1 Viral Escape in Infancy Followed by Emergence of a Variant-Specific CTL Response1

Philip J. R. Goulder, Todd M. Allen, Simon Mallal, 2005, The Journal of Immunology.

Quantitative Inhibition of Haemophilus influenzae by Trimethoprim/Sulfamethoxazole

M. Finland, J. Klein, S. Pelton, 1977, Antimicrobial Agents and Chemotherapy.

Neuropsychological Functioning and Viral Load in Stable Antiretroviral Therapy-Experienced HIV-Infected Children

R. Jeremy, P. Krogstad, S. Pelton, 2005, Pediatrics.

Acquired immunodeficiency syndrome: a new population of children at risk.

S. Pelton, E. Cooper, M. Lemay, 1988, Pediatric clinics of North America.

Reported use of antimicrobial agents in children attending a pediatric emergency department.

R. Vinci, S. Pelton, E. Barnett, 1991, The Pediatric infectious disease journal.

HLA-B57-Restricted Cytotoxic T-Lymphocyte Activity in a Single Infected Subject toward Two Optimal Epitopes, One of Which Is Entirely Contained within the Other

B. Walker, P. Goulder, Yanhua Tang, 2000, Journal of Virology.

The Global Meningococcal Initiative: recommendations for reducing the global burden of meningococcal disease.

A. Wilder-Smith, L. Harrison, S. Plotkin, 2011, Vaccine.

Sialic acid mediated transcriptional modulation of a highly conserved sialometabolism gene cluster in Haemophilus influenzae and its effect on virulence

D. Hood, S. Pelton, K. Makepeace, 2010, BMC Microbiology.

Differential Narrow Focusing of Immunodominant Human Immunodeficiency Virus Gag-Specific Cytotoxic T-Lymphocyte Responses in Infected African and Caucasoid Adults and Children

E. Rosenberg, M. Altfeld, B. Walker, 2000, Journal of Virology.

Management of the young febrile child: a continuing controversy.

H. Bauchner, S. Pelton, 1997, Pediatrics.

Epidemiology, Diagnosis, and Treatment of Serious Pneumococcal Infections in Children

S. Madhi, S. Pelton, 2008 .

Response Emergence of a Variant-Specific CTL HIV-1 Viral Escape in Infancy Followed by Altfeld ,

Todd M. Allen, M. Altfeld, B. Walker, 2005 .

Functionally Inert HIV-Specific Cytotoxic T Lymphocytes Do Not Play a Major Role in Chronically Infected Adults and Children

E. Rosenberg, M. Altfeld, B. Walker, 2000, The Journal of experimental medicine.

Antibody persistence and immunologic memory after sequential pneumococcal conjugate and polysaccharide vaccination in HIV-infected children on highly active antiretroviral therapy.

W. Borkowsky, M. Levin, S. Pelton, 2013, Vaccine.

Immunogenicity, immunologic memory, and safety following measles revaccination in HIV-infected children receiving highly active antiretroviral therapy.

W. Borkowsky, W. Bellini, M. Levin, 2012, The Journal of infectious diseases.

Sinusitis in children infected with human immunodeficiency virus: clinical characteristics, risk factors, and prophylaxis. National Institute of Child Health and Human Development Intravenous Immunoglobulin Clinical Trial Study Group.

S. Pelton, J. Moye, R. Nugent, 1995, Clinical infectious diseases : an official publication of the Infectious Diseases Society of America.

29 – Otitis Media

S. Pelton, 2018 .

New Concepts in the Pathophysiology and Management of Middle Ear Disease in Childhood

S. Pelton, 2012, Drugs.

Prevention of early episodes of otitis media by pneumococcal vaccines might reduce progression to complex disease.

L. Bakaletz, S. Pelton, R. Dagan, 2016, The Lancet. Infectious diseases.

Disparate cultures of middle ear fluids. Results from children with bilateral otitis media.

D. Teele, J. Klein, S. Pelton, 1980, American journal of diseases of children.

Parents, physicians, and antibiotic use.

H. Bauchner, J. Klein, S. Pelton, 1999, Pediatrics.

Pharmacokinetics of dapsone in children.

S. Pelton, M. Mirochnick, D. Clarke, 1993, The Journal of pediatrics.

Editorial: Otitis media

K. Mason, S. Pelton, R. Marsh, 2022, Frontiers in Cellular and Infection Microbiology.

Otitis media across nine countries: disease burden and management.

A. Schilder, S. Pelton, J. Liese, 2010, International journal of pediatric otorhinolaryngology.

Consensus: management of the child with a chronic draining ear.

M. Kenna, G. Mccracken, S. Pelton, 1985, Pediatric Infectious Disease.

Career choice in one general pediatric Title VII--supported residency.

H. Bauchner, R. Vinci, S. Pelton, 1995, Archives of pediatrics & adolescent medicine.

Host-derived sialic acid is incorporated into Haemophilus influenzae lipopolysaccharide and is a major virulence factor in experimental otitis media

J. Brisson, Jianjun Li, Gaynor A Randle, 2003, Proceedings of the National Academy of Sciences of the United States of America.

Prevention of Pneumococcal Disease in High-Risk Pediatric Groups

S. Pelton, 1999 .

The draining ear. Otitis media and externa.

J. Klein, S. Pelton, 1988, Infectious disease clinics of North America.

Otitis Media in the Newborn Infant

J. Klein, S. Pelton, P. Shurin, 1976, The Annals of otology, rhinology, and laryngology.

Trimethoprim-sulfamethoxazole compared with ampicillin in the treatment of acute otitis media.

J. Klein, S. Pelton, P. Shurin, 1980, The Journal of pediatrics.

Variability of Outer Membrane Protein P1 and Its Evaluation as a Vaccine Candidate against Experimental Otitis Media due to Nontypeable Haemophilus influenzae: an Unambiguous, Multifaceted Approach

P. Rice, Q. C. Truong-Bolduc, S. Pelton, 2000, Infection and Immunity.

Do children with recurrent Haemophilus influenzae otitis media become infected with a new organism or reacquire the original strain?

D. Granoff, S. Pelton, C. Marchant, 1984, The Journal of pediatrics.

Capacity of serotype 19A and 15B/C Streptococcus pneumoniae isolates for experimental otitis media: Implications for the conjugate vaccine

J. Gent, S. Pelton, M. Pettigrew, 2010, Vaccine.

Otitis media: current concepts in diagnosis and management.

S. Pelton, P. Whitley, 1983, Pediatric annals.

Xylitol Syrup for the Prevention of Acute Otitis Media

A. Mitchell, R. Vezina, S. Pelton, 2014, Pediatrics.

Multiple Consecutive Lavage Samplings Reveal Greater Burden of Disease and Provide Direct Access to the Nontypeable Haemophilus influenzae Biofilm in Experimental Otitis Media

H. Cabral, S. Ram, S. Pelton, 2007, Infection and Immunity.

Pediatric respiratory tract infections: etiology, microbiology and resistance trends. Introduction.

S. Pelton, 2003, The Pediatric infectious disease journal.

4. Microbiology, Immunology, Biochemistry, and Vaccination

D. L. Klein, A. Ryan, S. Juhn, 1989 .

Scope of Antibiotic Stewardship Programs in Pediatrics

S. Pelton, P. Astagneau, Kim T. Shea, 2019, Clinical pediatrics.

Experimental Acute Otitis Media Due to Nontypeable Haemophilus influenzae: Comparison of High and Low Azithromycin Doses with Placebo

F. Babl, S. Pelton, Zhong Li, 2002, Antimicrobial Agents and Chemotherapy.

Pediatric AIDS: Clinical, Pathologic, and Basic Science Perspectives. Conference proceedings. Washington, D.C., November 18-21, 1992.

Boechat, R. Elashoff, R. Mellins, 1993, Annals of the New York Academy of Sciences.

Population genomic datasets describing the post-vaccine evolutionary epidemiology of Streptococcus pneumoniae

Julian Parkhill, Marc Lipsitch, Nicholas J Croucher, 2015, Scientific Data.

Continued Impact of Pneumococcal Conjugate Vaccine on Carriage in Young Children

M. Lipsitch, W. Hanage, K. Kleinman, 2009, Pediatrics.

Cost-Effectiveness of Tdap Vaccination of Adults Aged ≥65 Years in the Prevention of Pertussis in the US: A Dynamic Model of Disease Transmission

M. Weinstein, B. Arondekar, G. Krishnarajah, 2014, PloS one.

Upper respiratory tract colonization with Streptococcus pneumoniae in adults

K. O'Brien, L. Danon, L. Hammitt, 2020, Expert review of vaccines.

Effectiveness of 13-Valent Pneumococcal Conjugate Vaccine Against Invasive Disease Caused by Serotype 3 in Children: A Systematic Review and Meta-analysis of Observational Studies

P. De Wals, B. Gessner, S. Pelton, 2018, Clinical infectious diseases : an official publication of the Infectious Diseases Society of America.

A second-generation pneumococcal conjugate vaccine for prevention of pneumococcal diseases in children

S. Pelton, Carlos G. Grijalva, 2011, Current opinion in pediatrics.

Invasive Pneumococcal Disease-Not Evenly Shared by All Children.

S. Pelton, I. Yildirim, R. Lapidot, 2019, JAMA pediatrics.

Epidemiology and risk factors for Staphylococcus aureus colonization in children in the post-PCV7 era

M. Lipsitch, W. Hanage, K. Kleinman, 2009, BMC infectious diseases.

Comparing the Clinical and Economic Outcomes Associated with Adjuvanted versus High-Dose Trivalent Influenza Vaccine among Adults Aged ≥ 65 Years in the US during the 2019–20 Influenza Season—A Retrospective Cohort Analysis

M. Postma, M. Levin, S. Pelton, 2021, Vaccines.

A retrospective cohort study assessing relative effectiveness of adjuvanted versus high-dose trivalent influenza vaccines among older adults in the United States during the 2018-19 influenza season.

M. Postma, G. Krishnarajah, S. Pelton, 2021, Vaccine.

A dynamic model of pneumococcal infection in the United States: implications for prevention through vaccination.

Matthew R Moore, Stephen I Pelton, C. Whitney, 2010, Vaccine.

Antibiotic-resistant Streptococcus pneumoniae in the heptavalent pneumococcal conjugate vaccine era: predictors of carriage in a multicommunity sample.

R. Platt, K. Kleinman, D. Goldmann, 2003, Pediatrics.

Streptococcus pneumoniae Serotype 6C: an Intra- and Interclonal Complex Comparison

Y. Kong, S. Pelton, J. Thomas, 2011, Journal of bacteriology.

Streptococcus pneumoniae Clonal Complex 199: Genetic Diversity and Tissue-Specific Virulence

M. Pichichero, Y. Kong, K. Fennie, 2011, PloS one.

Diversity and antibiotic resistance among nonvaccine serotypes of Streptococcus pneumoniae carriage isolates in the post-heptavalent conjugate vaccine era.

M. Lipsitch, W. Hanage, D. Godoy, 2007, The Journal of infectious diseases.

Inferring public health and vaccine policies from epidemiology and whole genome sequencing of invasive pneumococcal isolates from a surveillance network.

S. Pelton, R. Lapidot, 2020, Clinical infectious diseases : an official publication of the Infectious Diseases Society of America.

A real-world study evaluating the relative vaccine effectiveness of a cell-based quadrivalent influenza vaccine compared to egg-based quadrivalent influenza vaccine in the US during the 2017-18 influenza season.

M. Postma, G. Krishnarajah, S. Pelton, 2020, Vaccine.

Re-emergence of the type 1 pilus among Streptococcus pneumoniae isolates in Massachusetts, USA.

M. Lipsitch, W. Hanage, S. Rifas-Shiman, 2010, Vaccine.

Twenty-Year Public Health Impact of 7- and 13-Valent Pneumococcal Conjugate Vaccines in US Children

S. Pelton, K. Sutton, V. Snow, 2021, Emerging infectious diseases.

Diagnosis and treatment of upper respiratory tract infections in the primary care setting.

S. Saint, A. Fendrick, I. Brook, 2001, Clinical therapeutics.

Using pneumococcal carriage data to monitor postvaccination changes in invasive disease.

K. O'Brien, M. Lipsitch, E. Sanders, 2013, American journal of epidemiology.

Decline in Pneumococcal Disease Attenuated in Older Adults and Those With Comorbidities Following Universal Childhood PCV13 Immunization

S. Pelton, R. Sato, D. Weycker, 2018, Clinical infectious diseases : an official publication of the Infectious Diseases Society of America.

Seasonal Variation in Penicillin Susceptibility and Invasive Pneumococcal Disease

L. Madoff, S. Pelton, P. Iroh Tam, 2015, The Pediatric infectious disease journal.

Efficacy of Solithromycin (CEM-101) for Experimental Otitis Media Caused by Nontypeable Haemophilus influenzae and Streptococcus pneumoniae

S. Pelton, P. Fernandes, M. Figueira, 2016, Antimicrobial Agents and Chemotherapy.

The relative invasive disease potential of Streptococcus pneumoniae among children after PCV introduction: A systematic review and meta-analysis.

S. Madhi, E. Sanders, A. van der Ende, 2018, The Journal of infection.

Population genomics of pneumococcal carriage in Massachusetts children following introduction of PCV-13

M. Lipsitch, W. Hanage, N. Croucher, 2019, Microbial genomics.

Title Diversity and Antibiotic Resistance among Nonvaccine Serotypes of Streptococcus pneumoniae Carriage Isolates in the Post – Heptavalent Conjugate Vaccine

M. Lipsitch, W. Hanage, D. Godoy, 2007 .

Virulence of Streptococcus pneumoniae serotype 6C in experimental otitis media.

S. Pelton, M. Pettigrew, Vishakha Sabharwal, 2012, Microbes and infection.

Hepatocyte-specific mutation of both NF-κB RelA and STAT3 abrogates the acute phase response in mice.

Avrum Spira, Shizuo Akira, Stephen I Pelton, 2012, The Journal of clinical investigation.

Randomised trial of intradermal Mycobacterium vaccae or intradermal hepatitis B immunisation in children with HIV infection.

C. F. von Reyn, R. Arbeit, S. Pelton, 1999, Vaccine.

Cost-Effectiveness Analysis of Tdap in the Prevention of Pertussis in the Elderly

M. Weinstein, B. Arondekar, G. Krishnarajah, 2013, PloS one.

A Real-World Clinical and Economic Analysis of Cell-Derived Quadrivalent Influenza Vaccine Compared to Standard Egg-Derived Quadrivalent Influenza Vaccines During the 2019-2020 Influenza Season in the United States.

M. Postma, M. Levin, S. Pelton, 2021, Open forum infectious diseases.

Evidence that pneumococcal serotype replacement in Massachusetts following conjugate vaccination is now complete.

C. Fraser, W. Hanage, K. Kleinman, 2010, Epidemics.

Stability of the pneumococcal population structure in Massachusetts as PCV13 was introduced

M. Lipsitch, W. Hanage, N. Croucher, 2015, BMC Infectious Diseases.

Evolution of pneumococcal serotype epidemiology in Botswana following introduction of 13-valent pneumococcal conjugate vaccine

Samir S. Shah, A. Steenhoff, K. Feemster, 2022, PloS one.

Gradual decline in outpatient antibiotic prescriptions in paediatrics: A data warehouse–based 11‐year cohort study

S. Pelton, W. Adams, P. Astagneau, 2020, Acta paediatrica.

Pharmacokinetics of High-Dose Lopinavir-Ritonavir with and without Saquinavir or Nonnucleoside Reverse Transcriptase Inhibitors in Human Immunodeﬁciency Virus-Infected Pediatric and Adolescent Patients Previously Treated with Protease Inhibitors (cid:1) † PACTG 1038

W. Borkowsky, G. Aldrovandi, S. Pelton, 2008 .

Mortality and readmission in the year following hospitalization for pneumonia among US adults.

S. Pelton, R. Sato, D. Weycker, 2021, Respiratory medicine.

Community-acquired pneumonia in infants: Not simply an acute event with complete recovery.

S. Pelton, D. Weycker, R. Lapidot, 2021, Respiratory medicine.

The old man’s friend

S. Pelton, G. Rijkers, 2018, Pneumonia.

Antibiotic Prescribing in Outpatient Children: A Cohort From a Clinical Data Warehouse

S. Pelton, I. Camelo, W. Adams, 2019, Clinical pediatrics.

Baseline Resistance to Nucleoside Reverse Transcriptase Inhibitors Fails to Predict Virologic Response to Combination Therapy in Children (pactg 338)

L. Mofenson, Chengcheng Hu, S. Pelton, 2007 .

Stavudine, nevirapine and ritonavir in stable antiretroviral therapy-experienced children with human immunodeficiency virus infection.

L. Mofenson, S. Pelton, R. Yogev, 2002, The Pediatric infectious disease journal.

Evaluating the Relative Vaccine Effectiveness of Adjuvanted Trivalent Influenza Vaccine Compared to High-Dose Trivalent and Other Egg-Based Influenza Vaccines among Older Adults in the US during the 2017–2018 Influenza Season

M. Postma, G. Krishnarajah, S. Pelton, 2020, Vaccines.

Prevention of acute and recurrent otitis media

S. Pelton, 2000, The Lancet.

Cost-effectiveness analysis of BOOSTRIX® (Tetanus Toxoid, Reduced Diphtheria Toxoid and Acellular Pertussis Vaccine, Adsorbed) among Individuals≥ 65 years of age in prevention of Pertussis

M. Weinstein, B. Arondekar, G. Krishnarajah, 2012 .

Changing Serotypes Causing Childhood Invasive Pneumococcal Disease

S. Pelton, K. Hsu, K. Shea, 2010 .

Role of Complement in Host Defense against Pneumococcal Otitis Media

S. Ram, S. Pelton, Vishakha Sabharwal, 2009, Infection and Immunity.

Impact of PCV13 on Serotype 3 Invasive Pneumococcal Disease and Nasopharyngeal Carriage in Massachusetts’ Children

S. Pelton, K. Shea, I. Yildirim, 2017, Open Forum Infectious Diseases.

Evolution and transmission of stable CTL escape mutations in HIV infection

Michael Bunce, Robert Funkhouser, Christian Brander, 2001, Nature.

The decline in invasive pneumococcal disease.

S. Pelton, 2004, Pediatrics.

Improving the outcome of pneumococcal meningitis

S. Pelton, R. Yogev, 2005, Archives of Disease in Childhood.

Impact of 13-Valent Pneumococcal Conjugate Vaccination on Streptococcus pneumoniae Carriage in Young Children in Massachusetts.

Matthew D. Lakoma, W. Hanage, K. Kleinman, 2014, Journal of the Pediatric Infectious Diseases Society.

Seroreversion in human immunodeficiency virus‐exposed but uninfected infants

S. Pelton, E. Cooper, G. Hillyer, 1995, The Pediatric infectious disease journal.

Dapsone for prevention of Pneumocystis pneumonia in children with acquired immunodeficiency syndrome.

S. Pelton, E. Cooper, E. Barnett, 1994, The Pediatric Infectious Disease Journal.

Risk of exacerbation following pneumonia in adults with heart failure or chronic obstructive pulmonary disease

S. Pelton, R. Sato, D. Weycker, 2017, PloS one.

Baseline resistance to nucleoside reverse transcriptase inhibitors fails to predict virologic response to combination therapy in children (PACTG 338)

L. Mofenson, Chengcheng Hu, S. Pelton, 2007, AIDS Research and Therapy.

Enhancing Linkage to Hepatitis C Virus Treatment Following Pregnancy in Women Identified During Perinatal Care

S. Pelton, S. Lodi, E. Wachman, 2021, Hepatology communications.

Acute otitis media in an era of increasing antimicrobial resistance and universal administration of pneumococcal conjugate vaccine.

S. Pelton, 2002, The Pediatric infectious disease journal.

Baseline resistance to nucleoside reverse transcriptase inhibitors fails to predict virologic response to combination therapy in children (PACTG 338)

L. Mofenson, Chengcheng Hu, S. Pelton, 2007, AIDS research and therapy.

First Otitis Media and Pneumococcal Conjugate Vaccine Serotypes in Infants.

L. Bakaletz, S. Pelton, R. Dagan, 2018, The Pediatric infectious disease journal.

Serotype specific invasive capacity and persistent reduction in invasive pneumococcal disease.

M. Lipsitch, W. Hanage, K. Kleinman, 2010, Vaccine.